Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Ely Benaim
Age : 60
Public asset : 3,139,000 USD
Country of residence : Unknown
Linked companies : NovoCure Limited

Biography of Ely Benaim 
Ely Benaim is Chief Medical Officer at NovoCure Ltd. In the past Dr. Benaim occupied the position of Vice President-Clinical Affairs at Sangamo Therapeutics, Inc., Chief Medical Officer & SVP-Regulatory Affairs at Berg Pharma LLC, Senior Director-Clinical Research at Millennium Pharmaceuticals, Inc., Chief Medical Officer of Rexahn Pharmaceuticals, Inc., Senior Director-Global Oncology at Salmedix, Inc. and Assistant Professor at the University of Tennessee. Dr. Benaim received a doctorate from Central University of Venezuela.


Current positions of Ely Benaim 
Holdings of Ely Benaim 
Ely Benaim : Personal Network 
Most Read News 
06/22ELON MUSK : Musk says Tesla's new car factories 'losing billions of dollars'
RE
04:07aWARREN BUFFETT : Buffett's Berkshire buys more Occidental shares, raises stake to about 16.4%
RE
06/15ELON MUSK : Elon Musk appeals decision concerning SEC settlement over Twitter posts
RE
06/23MARK MILLER : Column-Want to do something about your ailing retirement savings? Don't
RE
06/22TREVOR MILTON : Nikola founder Trevor Milton faces new fraud charge
RE
06/22RUPERT MURDOCH : Rupert Murdoch and Jerry Hall are getting a divorce - NYT
RE
06/15PETER WENNINK : Samsung's Lee discusses smooth supply of "essential" chip equipment with ASML's Wennink
RE
06/14HAROLD HAMM : Billionaire-founder Harold Hamm offers to take Continental private in $25-billion deal
RE
06/21ELON MUSK : Musk says there are still a few unresolved matters with Twitter deal
RE
06/23MASAYOSHI SON : Nasdaq listing most likely for Arm - SoftBank's Son
RE
More news


© 2022 People and Ownership :   
Ely Benaim : Connections 


Latest news about Ely Benaim 
04/28TRANSCRIPT : NovoCure Limited, Q1 2022 Earnings Call, Apr 28, 2022
CI
02/24TRANSCRIPT : NovoCure Limited, Q4 2021 Earnings Call, Feb 24, 2022
CI
2021INSIDER TRENDS : Insider Continues Selling Trend at NovoCure
MT
2021TRANSCRIPT : NovoCure Limited, Q4 2020 Earnings Call, Feb 25, 2021
CI
2020TRANSCRIPT : NovoCure Limited - Shareholder/Analyst Call
CI
2020TRANSCRIPT : NovoCure Limited, Q3 2020 Earnings Call, Oct 29, 2020
CI
2020TRANSCRIPT : NovoCure Limited, Q2 2020 Earnings Call, Jul 30, 2020
CI
More news